TidalSense
TidalSense , a 13-year-old company based in Cambridge, UK, that develops a handheld breathing test that helps healthcare workers diagnose COPD from normal breathing without spirometry, raised a $19 million round.
Position in SVTR
Snapshot 2026-10-25- Startup SignalsRankedof 2,336↓93
- Life SciencesRankedof 247↓11
- Medtech DeviceRankedof 41↓3
About
TidalSense , a 13-year-old company based in Cambridge, UK, that develops a handheld breathing test that helps healthcare workers diagnose COPD from normal breathing without spirometry, raised a $19 million round. Investors included Cross-Border Impact Ventures as well as prior backers BGF , Airstream Capital , and Foresight Group .
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 7
Investor· 4
Founders / team· 2
Funding history
- 2026-07-24New funding round$19M
Investors · Airstream Capital, Foresight Group, BGF, Cross Border Impact VenturesSource · tidalsense.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- TidalSense
COPD diagnostic devices
2026-07
—
United States
BusinessLatest roundTotal raisedDate- Precision Neuroscience
building the next generation of brain-computer interfaces (BCIs) with a minimally invasive, high-density implant
Series D+ · $430M · 2026-09
$430M - Nervonik
Implantable peripheral nerve stimulation devices using electrical signals and real-time sensing for personalized chronic pain treatment
Series B · $53M · 2026-05
$53M - Proprio
AI-driven surgical platform startup building a system that makes surgeons more precise and multiplies surgical accuracy and efficiency
Series B · $43M · 2023-08
$43M
China
BusinessLatest roundTotal raisedDate- Krinwave
Super-resolution ultrasound imaging systems (kOS ultrasound operating system + HUS hardware platform), focused on transcranial brain ultrasound and clinical/research ultrasound diagnostics
Undisclosed · 2026-10
— - BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M - 深度医疗
R&D and manufacturing of the FUNZAR microsurgery robot for hospital ophthalmology, orthopedics, neurosurgery, plastic surgery and other departments, eliminating precision limits caused by hand tremor in microsurgery.
Series B · 2026-10
—
Europe
BusinessLatest roundTotal raisedDate- Hypervision Surgical
Surgical intelligence venture incubated at King's College London; AI-driven hyperspectral imaging assesses tissue status in real time during surgery
Series A · $23M · 2026-05
$23M - Nami Surgical
Miniature ultrasonic medical devices for surgery; high-performance small ultrasonic scalpels designed to overcome obstacles in robot-assisted surgery
Undisclosed · $4M · 2024-05
$4M - Soundsafe Care
Robotic focused ultrasound devices for noninvasive tumor ablation, launching first with veterinary certification, then expanding to human tumor treatment.
$2M
$2M
Other / unspecified
BusinessLatest roundTotal raisedDate- UltraSight
AI-guided cardiac ultrasound workflow platform (Echosystem) enabling non-specialist clinicians to perform diagnostic-grade echocardiograms at the bedside
Series B · $42M · 2026-09
$42M - Nuclivision
AI software that enhances PET scans for faster, lower-radiation imaging while maintaining diagnostic accuracy
Undisclosed · $6M · 2025-04
$6M - Sound Blade Medical
Handheld device that uses focused ultrasound to break down diseased tissue non-invasively
Series A · $17M · 2025-02
$17M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.